Dayra Therapeutics Announces Research Collaboration with Biogen

Wilson Sonsini Goodrich & Rosati has advised Dayra Therapeutics. Dayra Therapeutics, a biotechnology start-up focused on advancing oral macrocyclic peptide therapeutics, has entered into a research…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here